Product Information
PSB-603 is a small molecule that inhibits the P2Y receptors, which are involved in signal transduction pathways. It has been shown to induce neuronal death by inhibiting the activation of Epidermal Growth Factor Receptor (EGFR) and downstream signaling pathways. PSB-603 has also been shown to have anticancer activity in prostate cancer cells, as well as other types of cancer cells. PSB-603 inhibits proliferation and induces apoptosis in prostate cancer cells through inhibition of EGFR and cAMP levels. The mechanism of action for this drug is not fully understood, but it is thought that it may block transcription or translation processes.
PSB-603 has also been studied for its potential therapeutic applications in autoimmune diseases such as rheumatoid arthritis, lupus erythematosus, and multiple sclerosis. This drug may be used to prevent cartilage degradation by blocking the production of inflammatory cytokines such as TNF-α, IL-1β
Chemical properties
Technical inquiry about: 3D-STB35110 PSB-603
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.